Top Drug Execs Quizzed on Ways to Improve “Compassionate Use” Policies

Drugs the FDA Has Not Yet Approved are the Last Hope for Some Patients, Yet Access Often is Difficult National Center Senior Fellows Speak Directly with CEOs of Pfizer and Johnson & Johnson Short Hills, NJ / New Brunswick, NJ – Health policy experts with … Continue reading Top Drug Execs Quizzed on Ways to Improve “Compassionate Use” Policies